A Phase II Study of QL1706 With Anti-angiogenesis Therapy and Chemotherapy in Extensive-stage Small Cell Lung Cancer. | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase II Study of QL1706 With Anti-angiogenesis Therapy and Chemotherapy in Extensive-stage Small Cell Lung Cancer.	Extensive Small Cell Lung Cancer	Not yet recruiting	Phase 2	2025-07-24		NCT07083375

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Hebei Medical University Fourth Hospital	83
Peking University Cancer Hospital & Institute	189
Peking University People's Hospital	269
Renmin Hospital of Wuhan University	73
Shanxi Province Cancer Hospital	43
Tianjin Medical University Cancer Institute and Hospital	287
Wuhan TongJi Hospital	29
Zhijie Wang	3

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing 100021	Beijing	China	1